Introduction {#S1}
============

In humans, the killer immunoglobulin-like receptor*(KIR*) locus is mapped on the long arm of chromosome 19 within the leukocyte receptor complex (LRC). This locus is around 150 kb in length and includes 15 *KIR* genes arranged head-to-tail. The *KIR* loci that are currently known are *KIR2DL1*, *KIR2DL2*/*KIR2DL3*, *KIR2DL4*, *KIR2DL5A*, *KIR2DL5B*, *KIR2DS1-5*, *KIR3DL1*/*KIR3DS1*, *KIR3DL2-3*, and two pseudogenes, *KIR2DP1* and *KIR3DP1*. The *KIR* genes encode for two-dimensional (2D) and three-dimensional (3D) immunoglobulin-like domain receptors with short (S; activating) or long (L; inhibitory) cytoplasmic tails, which are expressed by natural killer (NK) cells and subsets of T cells. Copy number variation exhibited within the *KIR* locus forms diverse haplotypes with variable gene content^[@R1]^. Non-allelic homologous recombination (NAHR), facilitated by a close head-to-tail gene arrangement and high-sequence homology, is the mechanism proposed to be responsible for the haplotypic variability. Over 100 different haplotypes have been reported in populations worldwide^[@R1],[@R2],[@R3],[@R4]^. All these haplotypes could be divided into two major groups: A and B haplotypes. The A haplotype contains 7 *KIR* genes: *KIR3DL3*, *KIR2DL1*, *KIR2DL3*, *KIR2DL4*, *KIR3DL1*, and *KIR3DL2*, which are inhibitory *KIR* genes, and the activating *KIR* gene *KIR2DS4*. However, up to 70% of European-origin individuals who are homozygous for KIR haplotype A exclusively carry a non-functional \"deletion\" form of *KIR2DS4*^[@R5],[@R6]^. All other *KIR* gene combinations form group B haplotypes, including at least one of the specific *KIR* genes *KIR2DS1*, *KIR2DS2*, *KIR2DS3*, *KIR2DS5*, *KIR3DS1*, *KIR2DL2*, and *KIR2DL5*, and typically include two or more activating *KIR* genes.

HLA Class I molecules have been identified as the ligands for certain inhibitory receptors (*KIR2DL1*, *KIR2DL2*, *KIR2DL3*, and *KIR3DL1*), activating receptors (*KIR2DS1*, *KIR2DS2*, *KIR2DS4*, *KIR2DS5*, and *KIR3DS1*), and for *KIR2DL4*, which is a unique *KIR* that contains a long cytoplasmic tails like other inhibitory KIR receptors but also has a positively charged residue near the extracellular domain which is a common feature of other activating *KIR* receptors. The combination of variants within the KIR genes and the HLA genes influences receptor ligand interaction that shapes potential NK cell responsiveness at the individual level^[@R7],[@R8]^. Evidence from genetic association studies has indicated that *KIR* plays a role in viral resistance (e.g., human immunodeficiency virus \[HIV\]^[@R9]^ and hepatitis C virus \[HCV\]^[@R10]^), the success of transplantation^[@R11]^, the risk of pregnancy disorders and reproductive success^[@R12],[@R13]^, the protection against relapse after allogeneic hematopoietic stem cell transplantation (HSCT)^[@R14],[@R15],[@R16]^, and the risk of cancers^[@R17]^.

The combination of high-sequence homology and allelic and haplotypic diversity presents challenges in the task of accurately genotyping *KIR* genes. Conventional methods to type *KIR* genes include sequence-specific primer (SSP) polymerase chain reaction (PCR)^[@R18],[@R19],[@R20]^, sequence-specific oligonucleotide probe (SSOP) PCR^[@R21]^, and matrix assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS)^[@R22]^. The drawbacks of these techniques are that they only provide partial insight into the genotype of an individual whilst also being laborious to perform. Recently next-generation sequencing (NGS) has been applied to type the *KIR* locus specifically. While this method is very powerful, it can be expensive to run, and it is time-consuming to conduct in-depth analysis and data checks.

qKAT is a high-throughput quantitative PCR method. While conventional methods are laborious and time-consuming, this method makes it possible to run nearly 1,000 genomic DNA (gDNA) samples in five days and gives the *KIR* genotype, as well as the gene copy number. qKAT consists of ten multiplex reactions, each of which targets two *KIR* loci and one reference gene of a fixed copy number in the genome (*STAT6*) used for the relative quantification of the *KIR* gene copy number^[@R23]^. This assay has been successfully used in studies involving large population panels and disease cohorts on infectious diseases such as HCV, autoimmune conditions like type 1 diabetes, and pregnancy disorders such as preeclampsia, as well as providing a genetic underpinning to studies aimed at understanding the NK cell function^[@R1],[@R4],[@R24],[@R25],[@R26]^.

Protocol {#S2}
========

1. Preparation and Plating out of DNA {#S3}
-------------------------------------

1.  Accurately quantify the gDNA concentration using a spectrophotometric or fluorometric instrument.

2.  Dilute DNA to 4 ng/μL on a 96-well deep-well plate. Include at least one control gDNA sample with a known copy number and one non-template control.

3.  Centrifuge the 96-well plates at 450 x *g* for 2 min.

4.  Using a liquid handling instrument, dispense each sample in quadruplicate onto 384-well qPCR plates so that every well has 10 ng of DNA (2.5 μL/well). Prepare at least ten 384-well plates, one for each qKAT reaction.

5.  If gDNA is being dispensed from more than one 96-well plate, perform a full-volume wash with 2% bleach and ultrapure water to clean the needles of the liquid handling system between each 96-well plate of gDNA samples.

6.  Air-dry the DNA by incubating the 384-well plates in a clean area at room temperature for at least 24 h.

2. Preparation of the Primers and Probes {#S4}
----------------------------------------

**NOTE:** qKAT consists of ten multiplex reactions. Each reaction includes three primer pairs and three fluorescence-labeled probes that specifically amplify two *KIR* genes and one reference gene. The probes that were published in Jiang et al.^[@R27]^ were modified so that the oligonucleotides are now labeled with ATTO dyes since they offer improved photostability and long signal lifetimes. Pre-aliquoted primer combinations are commercially available (see **Table of Materials**).

1.  Prepare primer combinations for each reaction as per the dilutions given in [Table 1](#T1){ref-type="table"}.

2.  Prepare probe combinations for each reaction as per [Table 1](#T1){ref-type="table"}. Test each individual probe prior to making the combination.

3. Preparation of the Master Mix {#S5}
--------------------------------

**NOTE** The volumes mentioned below are for performing one qKAT reaction on a set of 10x 384-well plates.

1.  Ensure that the gDNA samples plated on the 384-well plates are completely dry. Conduct all steps on ice and keep the reagents covered from exposure to light as much as possible since the fluorescence-labeled probes are photo- and thermo-sensitive.

2.  Defrost the qPCR buffer, primer, and probe aliquots at 4 °C.

3.  On ice, prepare a master mix for 10x 384-well plates by adding 18.86 mL of ultrapure water, 20 mL of qPCR buffer, 1,000 μL of preprepared primer combination, and 180 μL of preprepared probe combination ([Table 2](#T2){ref-type="table"}).

4.  Distribute the master mix evenly across a 96-deep well plate using a multi-channel pipette, pipetting 415 μL into each well. Keep this plate in an ice box covered from light.

5.  Using a liquid handling instrument, dispense 9.5 μL of the master mix into each well of the 384-well plate with dried gDNA. Seal the plate with a foil and immediately place it at 4 °C. Repeat this process for the remaining plates, ensuring that the needles of the liquid handling system are washed with water between each plate.

6.  Centrifuge the 384-well plates at 450 x g for 3 min and incubate them at 4 °C overnight or between 6 - 12 h to resuspend the DNA and to dissipate any air bubbles.

4. qPCR Assay {#S6}
-------------

1.  Following the overnight incubation, centrifuge at 450 x *g* for 3 min to dissipate any remaining air bubbles.

2.  For purposes of automation, connect the qPCR machine (e.g., LightCycler 480) to a microplate handler (see **Table of Materials**). Program the microplate handler to place the plates into the qPCR machine from a cooled storage dock that is protected from light.

    **NOTE** The assays should, in theory, work on other qPCR machines with compatible optic settings.

3.  Use the following cycling conditions: 95 °C for 5 min followed by 40 cycles of 95 °C for 15 s and 66 °C for 50 s, with data collection at 66 °C.

4.  Once the run is complete, have the robot collect the plate from the qPCR machine and place it in the discard dock.

5. Post-run Analysis {#S7}
--------------------

1.  After amplification, calculate the quantification cycle (Cq) values using either the second derivative maximum method or the Fit Points method with the software of the qPCR machine (see **Table of Materials**), following the steps below.

2.  Open the qPCR software and, in the **Navigator** tab, open the saved reaction experiment file for one plate.

3.  **For the analysis using the second derivative maximum method, select the Analysis tab, and create a new analysis using Abs Quant/Second Derivative Max method**. In the **Create new analysis** window, select analysis type: **Abs Quant/Second Derivative Max method**, subset: **All Samples**, program: **Amplification**, name: **Rx-DFO** (where **x** is the reaction number).Select **Filter Comb** and choose **VIC/HEX/Yellow555 (533-580)**. This ensures that the data collected for *STAT6* is selected.Select **Colour Compensation** for **VIC/HEX/Yellow555(533-580)**. Click **Calculate**. Repeat this for Fam (465-510) and Cy5/Cy5.5(618-660). Click **Save file**.

4.  **For the analysis using the Fit Points method, select Abs Quant/Fit Points in the Analysis tab**. In the **Create new analysis**window, select analysis type: **Abs Quant/Fit Points method**, subset: **All Samples**, program: **Amplification**, name: **RxF-DFO**(where **x** is the reaction number).Select the correct filters and color compensations for *STAT6* and each of the *KIR* genes (Fam/Cy5). In the **Noiseband** tab, set the noise band to exclude the background noise.In the **Analysis** tab, set the fit points to **3** and select **Show fit points**. Click **Calculate**. Click **Save file**.

6. Export of the Results {#S8}
------------------------

1.  In the qPCR software, open the **Navigator** tab. Select **Results Batch Export**.

2.  Open the folder in which the experiment files are saved and transfer the files into the right-hand side section of the window. Click **Next**. Select the name and the location of the export file.

3.  Select Analysis type **Abs Quant/Second Derivative Max method** or **Abs Quant/Fit Points**. Click **Next**. Check that the name of the file, the export folder, and the analysis type are correct and click **Next** to start the export process.

4.  Wait until the **Export Status** is **Ok**. The screen will automatically move to the next step. Check that all selected files have been exported successfully so that the number of files failed = 0. Click **Done**.

5.  Use scripts split_file.pl and roche2sds.pl to split the exported plates into individual reactions for each plate.

    **NOTE** The scripts are provided on request/GitHub.

7. Copy Number Calculations {#S9}
---------------------------

1.  Open the copy number analysis software (e.g., CopyCaller). Select **Import real-time PCR results file** and load text files created by **roche2sds.pl**.

2.  Select **Analyze** and conduct the analysis by either selecting **calibrator sample with known copy number** or by selecting **most frequent copy number**. See [Table 5](#T5){ref-type="table"} for the most frequent copy number of *KIR* genes typically observed in European-origin populations.

8. Data-quality Checks {#S10}
----------------------

1.  Use R script **KIR_CNVdata_analysis_for_Excel_ver020215.R** to combine copy number data from all the plates into a spreadsheet.

    **NOTE** The scripts are provided on request/GitHub.

2.  Recheck the raw data on the copy number analysis software for samples that do not conform to the known linkage disequilibrium (LD) for *KIR* genes ([Table 6](#T6){ref-type="table"}).

Representative Results {#S11}
======================

Copy number analysis can be carried out by exporting the files to the copy number analysis software, which provides the predicted and estimated copy number based on the ΔΔCq method.

The copy number can be predicted either based on the known copy number of control DNA samples on the plate or by inputting the most frequent gene copy number ([Table 5](#T5){ref-type="table"}). [Figure 1](#F1){ref-type="fig"} shows the results of a plate for a reaction that targets *KIR2DL4* and *KIR3DS1*, as well as the reference gene *STAT6.* The most frequent copy number for *KIR2DL4,* a framework gene in the *KIR* locus, is two copies, whereas the most frequent copy number for *KIR3DS1*, an activating gene, is one copy. The results in the figure show the PCR amplification plots observed on the qPCR software and the copy number data generated from the qPCR data. As shown, the assay is able to distinguish between 0, 1, 2, 3, and 4 *KIR* gene copy numbers. The copy number analysis software also enables a viewing of the distribution of the copy number across the plate as a pie chart or a bar graph. The efficacy of the copy number prediction is lower for samples with a higher copy number.

The quality of all the materials used in the reactions, gDNA, buffer, primers, and probes, can affect the accuracy of the results obtained. However, discordance in results is most likely to be caused due to variation in the concentration of DNA across a plate. The purity of the extracted gDNA, which can be measured using the 260/280 and 260/230 ratios, can also have an effect on the quality. A 260/280 ratio of 1.8 - 2 and a 260/230 ratio of 2 - 2.2 are desirable. An uneven range of DNA concentrations across a plate can lead to a high variability in the threshold cycle (C~t~) between samples and discordance in the range of the estimated copy number. The results in [Figure 2](#F2){ref-type="fig"} show the effect the disparity between the C~t~ values across a plate can have on the accuracy in the prediction of the copy number. The red line indicates the range of the estimated copy number for a sample and, ideally, should be as close to an integer as possible.

The copy number data, once analyzed, can be exported as a spreadsheet file in a 96-well format. We used an R script (available on request) to combine the copy number data of all 10 plates that are run as a set into one spreadsheet. Published data about *KIRs* from mostly European-origin populations enables the prediction of LD rules that exist between various genes in the *KIR* complex^[@R1]^. These predictions are used to conduct downstream checks on the copy number results obtained ([Table 6](#T6){ref-type="table"}). Samples that do not conform to the predicted LD between the genes might contain unusual polymorphism or haplotypic structural variations. A flowchart describing the protocol is shown in [Figure 3](#F3){ref-type="fig"}.

A tool called *KIR* Haplotype Identifier ([http://www.bioinformatics.cimr.cam.ac.uk/haplotypes/](https://www.bioinformatics.cimr.cam.ac.uk/haplotypes/)) was developed to facilitate the imputation of haplotypes from the data set. The imputation works on the basis of a list of reference haplotypes observed in a European-origin population^[@R1]^. However, the tool also allows for a custom set of reference haplotypes to be used instead. Three separate files are generated; the first file lists all haplotype combinations for a sample, the second file provides a trimmed list of the haplotypes combinations that have the highest combined frequencies, and the third file lists the samples that cannot be assigned haplotypes. Non-assignment of haplotypes could be used as an indicator of novel haplotypes.

Discussion {#S12}
==========

We described a novel semi-automated high-throughput method, called qKAT, which facilitates copy number typing of *KIR* genes. The method is an improvement over conventional methods like SSP-PCR, which are low-throughput and can only indicate the presence or absence of these highly polymorphic genes.

The accuracy of the copy number data obtained is dependent on multiple factors, including the quality and concentration-uniformity of the gDNA samples and the quality of the reagents. The quality and accuracy of the gDNA samples across a plate are extremely important since variations in concentration across the plate can result in errors in the calculation of the copy number. Since the assays were validated using European-origin sample sets, data from cohorts from other parts of the world require more thorough checks. This is to ensure that instances of allele dropout or non-specific primer/probe binding are not misinterpreted as copy number variation.

While the assays were designed and optimized to run as high-throughput, they can be modified to run fewer samples. The confidence metric in the copy number analysis software is affected when analyzing fewer samples, but this can be improved if control genomic DNA samples with a known *KIR* gene copy number are included on the plate and additional sample replicates are included.

For laboratories without liquid/plate-handling robots, master mix can be dispensed using multi-channel pipettes and plates can be manually loaded into the qPCR instrument.

The main aim behind the development of qKAT was to create a simple, high-throughput, high-resolution, and cost-effective method to genotype *KIRs* for disease association studies. This was successfully achieved since qKAT has been employed in investigating the role of *KIR* in several large disease association studies, including a range of infectious diseases, autoimmune conditions, and pregnancy disorders^[@R4],[@R24],[@R25],[@R26]^.

The project received funding from the Medical Research Council (MRC), the European Research Council (ERC) under the European Union\'s Horizon 2020 research and innovation programme (grant agreement No. 695551) and the National Institute of Health (NIH) Cambridge Biomedical Research Centre and NIH Research Blood and Transplant Research Unit (NIHR BTRU) in Organ Donation and Transplantation at the University of Cambridge and in partnership with NHS Blood and Transplant (NHSBT). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, the Department of Health, or the NHSBT.
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(**A**) This panel shows amplification plots. (**B**) This panel shows copy number plots. (**C**) This panel shows the copy number distribution. [Please click here to view a larger version of this figure](https://www.jove.com/files/ftp_upload/58646/58646fig1v2large.jpg).](EMS84585-f001){#F1}

![Representative results of a plate with a variable DNA concentration for reaction number 5.\
(**A**) This panel shows amplification plots. (**B**) This panel shows copy number plots. [Please click here to view a larger version of this figure](https://www.jove.com/files/ftp_upload/58646/58646fig2v2large.jpg).](EMS84585-f002){#F2}
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###### Combination and concentration of primers and probes used in each qKAT reaction^[@R27]^.

  Assay           Genes          Forward Primers   Concentration (nM)   Reverse Primers   Concentration (nM)   Probes   Concentration (nM)
  --------------- -------------- ----------------- -------------------- ----------------- -------------------- -------- --------------------
  **No 1**        ***3DP1***     A4F               250                  A5R               250                  P4a      150
  ***2DL2***      2DL2F4         400               C3R2                 600               P5b                  150      
  ***STAT6***     STAT6F         200               STAT6R               200               PSTAT6               150      
  **No 2**        ***2DS2***     A4F               400                  A6R               400                  P4a      200
  ***2DL3***      D1F            400               D1R                  400               P9                   150      
  ***STAT6***     STAT6F         200               STAT6R               200               PSTAT6               150      
  **No 3**        ***3DL3***     A8F               500                  A8R               500                  P4a      150
  ***2DS4Del***   2DS4Del        250               2DS4R2               250               P5b                  150      
  ***STAT6***     STAT6F         200               STAT6R               200               PSTAT6               150      
  **No 4**        ***3DL1e4***   B1F               250                  B1R               125                  P4b      150
  ***3DL1e9***    D4F            250               D4R2                 500               P9                   150      
  ***STAT6***     STAT6F         200               STAT6R               200               PSTAT6               150      
  **No 5**        ***3DS1***     B2F               250                  B1R               250                  P4b      150
  ***2DL4***      C1F            200               C1R                  200               P5b-2DL4             150      
  ***STAT6***     STAT6F         200               STAT6R               200               PSTAT6               150      
  **No 6**        ***2DL1***     B3F               500                  B3R               125                  P4b      150
  ***2DP1***      D3F            250               D3R                  500               P9                   150      
  ***STAT6***     STAT6F         200               STAT6R               200               PSTAT6               150      
  **No 7**        ***2DS1***     B4F               500                  B4R               250                  P4b      150
  ***2DL5***      D2F            500               D2R                  500               P9                   150      
  ***STAT6***     STAT6F         200               STAT6R               200               PSTAT6               150      
  **No 8**        ***2DS3***     B5F               250                  B5R               250                  P4b      150
  ***3DL2e9***    D4F            250               D5R                  125               P9                   150      
  ***STAT6***     STAT6F         200               STAT6R               200               PSTAT6               150      
  **No 9**        ***3DL2e4***   A1F               200                  A1R               200                  P4a      150
  ***2DS4FL***    2DS4FL         250               2DS4R2               500               P5b                  150      
  ***STAT6***     STAT6F         200               STAT6R               200               PSTAT6               150      
  **No 10**       ***2DS5***     B6F2              200                  B6R3              200                  P4b      150
  ***2DS4***      C5F            250               C5R                  250               P5b                  150      
  ***STAT6***     STAT6F         200               STAT6R               200               PSTAT6               150      

###### Volumes (μL) of 100 μM primer/probe stock solutions to make primer and probe combination aliquots.

  Reaction                                     Primer Aliquots (μL)                             Probe Aliquots (μL)                                                            
  ---------- --------------- ---------- ------ ---------------------- -------- ------- -------- --------------------- ---------------------------------------------- --------- --------
  **R1**     **3DP1**        A4F        A5R    2DL2F4                 C3R2     WATER   STAT6F   STAT6R                P4A                                            P5B       PSTAT6
             **2DL2**        100        100    160                    240      200     80       80                    60                                             60        60
  **R2**     **2DS2**        A2F        A6R    D1F                    D1R      WATER   STAT6F   STAT6R                P4A                                            P9        PSTAT6
             **2DL3**        160        160    160                    160      160     80       80                    **80**                                         60        60
                                                                                                                      Note: need 20 μL less water in the MasterMix             
  **R3**     **3DL3**        A8F A8FB   A8R    2DS4DELF               2DS4R2   WATER   STAT6F   STAT6R                P4A                                            P5B       PSTAT6
             **2DS4DEL**     100 100    200    100                    100      200     80       80                    60                                             60        60
  **R4**     **3DL1E4**      B1F        B1R    D4F                    D4R2     WATER   STAT6F   STAT6R                P4B                                            P9        PSTAT6
             **3DL1E9**      100        50     100                    200      350     80       80                    60                                             60        60
  **R5**     **3DS1**        B2F        B1R    C1F                    C1R      WATER   STAT6F   STAT6R                P4B                                            P5B-2L4   PSTAT6
             **2DL4**        100        100    80                     80       440     80       80                    60                                             60        60
  **R6**     **2DL1**        B3F        B3R    D3F                    D3R      WATER   STAT6F   STAT6R                P4B                                            P9        PSTAT6
             **2DP1**        200        50     100                    200      250     80       80                    60                                             60        60
  **R7**     **2DS1**        B4F        B4R    D2F                    D2R      WATER   STAT6F   STAT6R                P4B                                            P9        PSTAT6
             **2DL5**        200        100    200                    200      100     80       80                    60                                             60        60
  **R8**     **2DS3**        B5F        B5R    D4F                    D5R      WATER   STAT6F   STAT6R                P4B                                            P9        PSTAT6
             **3DL2E9**      100        100    100                    50       450     80       80                    60                                             60        60
  **R9**     **3DL2E4**      A1F        A1R    2DS4WTF                2DS4R2   WATER   STAT6F   STAT6R                P4A                                            P5B       PSTAT6
             **2DS4WT**      80         80     100                    200      340     80       80                    60                                             60        60
  **R10**    **2DS5**        B6F2       B6R3   C5F                    C5R      WATER   STAT6F   STAT6R                P4B                                            P5B       PSTAT6
             **2DS4TOTAL**   80         80     100                    100      440     80       80                    60                                             60        60

###### List of probes used in qKAT[@R1],[@R27].

The fluorescent dyes used at the 5\' end of the oligo probes P5b, P5b-2DL4, P9, and PSTAT6 were modified to ATTO dyes.

  Name           Direction   5´ modification   3´ modification   Sequence (5\'→3\')             Length   Tm   GC%    Exon   Position
  -------------- ----------- ----------------- ----------------- ------------------------------ -------- ---- ------ ------ -----------
  **P4a**        Sense       FAM               BHQ-1             TCATCCTGCAATGTTGGTCAGATGTCA    27       60   44.4   4      425-451
  **P4b**        Antisense   FAM               BHQ-1             AACAGAACCGTAGCATCTGTAGGTCCCT   28       62   50     4      576-603
  **P5b**        Sense       ATTO647N          BHQ-2             AACATTCCAGGCCGACTTTCCTCTG      25       60   52     5      828-852
  **P5b-2DL4**   Sense       ATTO647N          BHQ-2             AACATTCCAGGCCGACTTCCCTCTG      25       61   56     5      828-852
  **P9**         Sense       ATTO647N          BHQ-2             CCCTTCTCAGAGGCCCAAGACACC       24       60   62.5   9      1246-1269
  **PSTAT6**                 ATTO550           BHQ-2             CTGATTCCTCCATGAGCATGCAGCTT     26       62   50            

###### Sequences of the primers used in qKAT^[@R1],[@R27]^.

  Gene          Primers   Direction   Sequence (5´-3´)          Length   Tm   GC%    Exon   Position    Amplicon (bp)   Alleles might be missed
  ------------- --------- ----------- ------------------------- -------- ---- ------ ------ ----------- --------------- ---------------------------------------------------------------------------------------------
  **3DL2e4**    A1F       Forward     GCCCCTGCTGAAATCAGG        18       52   61.1   4      399-416     179             3DL2\*008, \*021, \*027, \*038.
                A1R       Reverse     CTGCAAGGACAGGCATCAA       19       53   52.6          559-577                     3DL2\*048
  **3DP1**      A4F       Forward     GTCCCCTGGTGAAATCAGA       19       49   52.6   4      398-416     112             None
                A5R       Reverse     GTGAGGCGCAAAGTGTCA        18       52   55.6          492-509                     None
  **2DS2**      A2F       Forward     GTCGCCTGGTGAAATCAGA       19       49   52.6   4      398-416     111             None
                A6R       Reverse     TGAGGTGCAAAGTGTCCTTAT     21       51   42.9          488-508                     None
  **3DL3**      A8Fa      Forward     GTGAAATCGGGAGAGACG        18       50   55.6   4      406-423     139             None
                A8Fb      Forward     GGTGAAATCAGGAGAGACG       19       50   52.6          405-423                     3DL3\*054, 3DL3\*00905.
                A8R       Reverse     AGTTGACCTGGGAACCCG        18       51   61.1          526-543                     None
  **3DL1e4**    B1F       Forward     CATCGGTCCCATGATGCT        18       51   55.6   4      549-566     85              3DL1\*00505, 3DL1\*006, 3DL1\*054, 3DL1\*086, 3DL1\*089
                B1R       Reverse     GGGAGCTGACAACTGATAGG      20       52   55            614-633                     3DL1\*00502
  **3DS1**      B2F       Forward     CATCGGTTCCATGATGCG        18       51   55.6   4      549-566     85              3DS1\*047; may pick up 3DL1\*054.
                B1R       Reverse     GGGAGCTGACAACTGATAGG      20       52   55            614-633                     None
  **2DL1**      B3F       Forward     TTCTCCATCAGTCGCATGAC      20       52   50     4      544-563     96              2DL1\*020, 2DL1\*028
                B3R       Reverse     GTCACTGGGAGCTGACAC        18       50   61.1          622-639                     2DL1\*023, 2DL1\*029, 2DL1\*030
  **2DS1**      B4F       Forward     TCTCCATCAGTCGCATGAA       19       51   47.4   4      545-563     96              2DS1\*001
                B4R       Reverse     GGTCACTGGGAGCTGAC         17       49   64.7          624-640                     None
  **2DS3**      B5F       Forward     CTCCATCGGTCGCATGAG        18       53   61.1   4      546-563     96              None
                B5R       Reverse     GGGTCACTGGGAGCTGAA        18       51   61.1          624-641                     None
  **2DS5**      B6F2      Forward     AGAGAGGGGACGTTTAACC       19       50   52.6   4      475-493     173             None
                B6R3      Reverse     TCCAGAGGGTCACTGGGC        18       53   66.7          630-647                     2DS5\*003
  **2DL4**      C1F       Forward     GCAGTGCCCAGCATCAAT        18       52   55.6   5      808-825     83              None
                C1R       Reverse     CCGAAGCATCTGTAGGTCT       19       52   52.6          872-890                     2DL4\*018, 2DL4\*019
  **2DL2**      2DL2F4    Forward     GAGGTGGAGGCCCATGAAT       19       52   57.9   5      778-796     151             2DL2\*009; 782G changed to A.
                C3R2      Reverse     TCGAGTTTGACCACTCGTAT      20       51   45            909-928                     None
  **2DS4**      C5F       Forward     TCCCTGCAGTGCGCAGC         17       57   70.6   5      803-819     120             None
                C5R       Reverse     TTGACCACTCGTAGGGAGC       19       52   57.9          904-922                     2DS4\*013
  **2DS4Del**   2DS4Del   Forward     CCTTGTCCTGCAGCTCCAT       19       54   57.9   5      750-768     203             None
                2DS4R2    Reverse     TGACGGAAACAAGCAGTGGA      20       53   50            933-952                     None
  **2DS4FL**    2DS4FL    Forward     CCGGAGCTCCTATGACATG       19       53   57.9   5      744-762     209             None
                2DS4R2    Reverse     TGACGGAAACAAGCAGTGGA      20       53   50            933-952                     None
  **2DL3**      D1F       Forward     AGACCCTCAGGAGGTGA         17       48   58.8   9      1180-1196   156             None
                D1R       Reverse     CAGGAGACAACTTTGGATCA      20       50   45            1316-1335                   2DL3\*010, 2DL3\*017, 2DL3\*01801 and 2DL3\*01802
  **2DL5**      D2F       Forward     CACTGCGTTTTCACACAGAC      20       52   50     9      1214-1233   120             2DL5B\*011 and 2DL5B\*020
                D2R       Reverse     GGCAGGAGACAATGATCTT       19       49   47.4          1315-1333                   None
  **2DP1**      D3F       Forward     CCTCAGGAGGTGACATACGT      20       53   55     9      1184-1203   121             None
                D3R       Reverse     TTGGAAGTTCCGTGTACACT      20       50   45            1285-1304                   None
  **3DL1e9**    D4F       Forward     CACAGTTGGATCACTGCGT       19       52   52.6   9      1203-1221   93              3DL1\*061, 3DL1\*068
                D4R2      Reverse     CCGTGTACAAGATGGTATCTGTA   23       53   43.5          1273-1295                   3DL1\*05901, 3DL1\*05902, 3DL1\*060, 3DL1\*061, 3DL1\*064, 3DL1\*065, 3DL1\*094N, 3DL1\*098
  **3DL2e9**    D4F       Forward     CACAGTTGGATCACTGCGT       19       52   52.6   9      1203-1221   156             None
                D5R       Reverse     GACCTGACTGTGGTGCTCG       19       54   63.2          1340-1358                   None
  **STAT6**     STAT6F    Forward     CCAGATGCCTACCATGGTGC      20       54   60                        129             
                STAT6R    Reverse     CCATCTGCACAGACCACTCC      20       54   60                                        

###### Most frequent copy number for *KIR* genes commonly observed in European-origin samples.

  *KIR* gene                      3DL3   2DS2   2DL2   2DL3   2DP1   2DL1   3DP1   2DL4   3DL1 EX9   3DL1 EX9   3DS1   2DL5   2DS3   2DS5   2DS1   2DS4 Total   2DS4 FL   2DS4 DEL   3DL2 ex4   3DL2 EX9
  ------------------------------- ------ ------ ------ ------ ------ ------ ------ ------ ---------- ---------- ------ ------ ------ ------ ------ ------------ --------- ---------- ---------- ----------
  **Most frequent copy number**   2      1      1      2      2      2      2      2      2          2          1      1      1      1      1      2            1         1          2          2

###### Linkage disequilibrium between *KIR* genes commonly observed in European-origin populations can be used to check copy number data^[@R1],[@R27]^.

           Linkage disequilibrium rules for qKAT based on European populations                             Copy number check
  -------- ----------------------------------------------------------------------------------------------- ----------------------------------------------
  **1**    *KIR3DL3, KIR3DP1,KIR2DL4* and *KIR3DL2* are framework genes present on both haplotypes.        *KIR3DL3, KIR3DP1,KIR2DL4* and *KIR3DL2* = 2
  **2**    *KIR2DS2* and *KIR2DL2* are in LD with each other                                               *2DS2*=*2DL2*
  **3**    *KIR2DL2* and *KIR2DL3* are alleles of the same gene                                            *2DL2*+*2DL3*=2
  **4**    *KIR2DP1* and *KIR2DL1* are in LD with each other                                               *2DP1*=*2DL1*
  **5**    Exon 4 of *KIR3DL1* and *KIR3DL2* is equal to exon 9 of *KIR3DL1* and *KIR3DL2* respectively.   *3DL1ex4*=*3DL1ex9* AND *3DL2ex4*=*3DL2ex9*
  **6**    *KIR3DL1* and *KIR3DS1* are alleles                                                             *3DL1*+*3DS1*=2
  **7**    *KIR2DS3* and *KIR2DS5* are in LD with *KIR2DL5*                                                *2DS3*+*2DS5*=*2DL5*
  **8**    *KIR3DS1* and *KIR2DS1* are in LD                                                               *3DS1*=*2DS1*
  **9**    Presence of *KIR2DS1* and *KIR2DS4T*otal is mutually exclusive on a haplotype                   *2DS1*+*2DS4TOTAL*=2
  **10**   *KIR2DS4FL* and *KIR2DS4del* are variants of *KIR2DS4TOTAL*                                     *2DS4FL*+*2DS4DEL*=*2DS4TOTAL*

[^1]: **Video Link**

    The video component of this article can be found at [https://www.jove.com/video/58646/](https://www.jove.com/video/58646/qkat-quantitative-semi-automated-typing-killer-cell-immunoglobulin)
